Search results for " Tumors"

showing 10 items of 1017 documents

Cavernous hemangioma of the parotid gland in adults

2014

Hemangiomas account for 0.4-0.6% of all tumors of the parotid gland and most of them occur in children, nevertheless in adults hemangiomas are very rare. We report the case of a 62 year old woman with a mass in the parotid right tail associated with fluctuating swelling episodes unrelated to meals and with a slowly progressive growth. The provisional diagnosis was a pleomorphic adenoma, so a right superficial parotidectomy was performed. During surgery, the macroscopic appearance makes suspect a vascular lesion. The histopathological result was a cavernous hemangioma. The classic clinical presentation of a parotid hemangioma is an intraglandular mass associated or not with skin lesions char…

medicine.medical_specialtyPathologyCase ReportOdontologíaHemangiomaPleomorphic adenomastomatognathic systemmedicinecardiovascular diseasesGeneral Dentistrybusiness.industryVascular malformation:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludeye diseasesParotid glandstomatognathic diseasesParotid Regionmedicine.anatomical_structureSuperficial ParotidectomyUNESCO::CIENCIAS MÉDICASParotid tumorssense organsRadiologyOral SurgeryDifferential diagnosisbusinessJournal of Clinical and Experimental Dentistry
researchProduct

In Vivo Molecular Imaging of Somatostatin Receptors in Pancreatic Islet Cells and Neuroendocrine Tumors by Miniaturized Confocal Laser-Scanning Fluor…

2010

The aim of the study was to evaluate real time in vivo molecular imaging of somatostatin receptors (sstrs) using a handheld miniaturized confocal laser scan microscope (CLM) in conjunction with fluorescein-labeled octreotate (OcF) in healthy mice and murine models of neuroendocrine tumors. For CLM a small rigid probe (diameter 7 mm) with an integrated single line laser (488 nm) was used (optical slice thickness 7 μm; lateral resolution 0.7 μm). OcF was synthesized via Fmoc solid-phase peptide synthesis and purified by HPLC showing high-affinity binding to the sstr2 (IC50 6.2 nmol). For in vitro evaluation, rat and human pancreatic cancer cells were used and characterized with respect to its…

medicine.medical_specialtyPathologyConfocalEndocrinology Diabetes and MetabolismClinical BiochemistryMice NudeNeuroendocrine tumorsOctreotideBinding CompetitiveBiochemistryIslets of LangerhansMiceEndocrinologyIn vivoInternal medicinePancreatic cancerCell Line TumormedicineSomatostatin receptor 2AnimalsHumansReceptors SomatostatingeographyMice Inbred BALB Cgeography.geographical_feature_categoryMicroscopy ConfocalMiniaturizationChemistrySomatostatin receptorReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingBiochemistry (medical)Reproducibility of Resultsmedicine.diseaseIsletFluoresceinsImmunohistochemistryMolecular ImagingNeuroendocrine TumorsEndocrinologyEx vivoThe Journal of Clinical Endocrinology & Metabolism
researchProduct

NeXt for neuro-radiosurgery: A fully automatic approach for necrosis extraction in brain tumor MRI using an unsupervised machine learning technique

2017

Stereotactic neuro-radiosurgery is a well-established therapy for intracranial diseases, especially brain metastases and highly invasive cancers that are difficult to treat with conventional surgery or radiotherapy. Nowadays, magnetic resonance imaging (MRI) is the most used modality in radiation therapy for soft-tissue anatomical districts, allowing for an accurate gross tumor volume (GTV) segmentation. Investigating also necrotic material within the whole tumor has significant clinical value in treatment planning and cancer progression assessment. These pathological necrotic regions are generally characterized by hypoxia, which is implicated in several aspects of tumor development and gro…

medicine.medical_specialtyPathologyING-INF/06 - BIOINGEGNERIA ELETTRONICA E INFORMATICAmedicine.medical_treatmentunsupervisedFuzzy C-Means clusteringBrain tumorRadiosurgeryING-INF/05 - SISTEMI DI ELABORAZIONE DELLE INFORMAZIONI030218 nuclear medicine & medical imaging03 medical and health sciencesnecrosis extraction0302 clinical medicineMagnetic resonance imagingmedicineSegmentationElectrical and Electronic EngineeringRadiation treatment planningmedicine.diagnostic_testSettore INF/01 - Informaticabusiness.industryneuro-radiosurgery treatmentsNeuro-radiosurgery treatmentbrain tumors; magnetic resonance imaging; necrosis extraction; neuro-radiosurgery treatments; unsupervisedFuzzy C-Means clustering;brain tumors; magnetic resonance imaging; necrosis extraction; neuro-radiosurgery treatments; unsupervised Fuzzy C-Means clusteringCancerINF/01 - INFORMATICAMagnetic resonance imagingmedicine.diseaseElectronic Optical and Magnetic MaterialsRadiation therapyunsupervised Fuzzy C-Means clusteringBrain tumorUnsupervised learningbrain tumorsComputer Vision and Pattern RecognitionRadiologybusiness030217 neurology & neurosurgerySoftware
researchProduct

Expression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract

2003

Expression of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) helps to establish the origin of biliary and metastatic carcinomas. We investigated the expression of CK7 and CK20 in inflammatory, metaplastic and neoplastic conditions of the bile ducts, and evaluated possible relationships between the CK expression pattern and extrahepatic bile duct/gallbladder carcinomas (EBDCs) or intrahepatic bile duct carcinomas (IBDCs). We used immunohistochemistry for the investigation of 48 formalin-fixed, paraffin-embedded specimens grouped as: A) lithiasic or inflamed surgically resected extrahepatic bile ducts/gallbladders: all were CK7+/CK20+; B) percutaneous liver biopsies from patients with chronic …

medicine.medical_specialtyPathologyIntestinal metaplasia2734Intrahepatic bile ductsBile duct tumors; Cytokeratin 20 (CK20); Cytokeratin 7 (CK7); Intestinal metaplasia; Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts Extrahepatic; Bile Ducts Intrahepatic; Carcinoma; Cell Transformation Neoplastic; Gallbladder Diseases; Gallbladder Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Intermediate Filament Proteins; Keratin-20; Keratin-7; Keratins; 2734Bile Duct DiseasesGallbladder DiseasesKeratin-20Settore MED/08 - Anatomia PatologicaGastroenterologyIntermediate Filament ProteinPathology and Forensic MedicinePrimary sclerosing cholangitisCytokeratinPrimary biliary cirrhosisIntermediate Filament ProteinsBile Ducts ExtrahepaticInternal medicineBile duct tumormedicineHumansCytokeratin 7 (CK7)Bile Duct NeoplasmGallbladder NeoplasmBile ductbusiness.industryGene Expression ProfilingGallbladderKeratin 20CarcinomaGallbladder DiseaseKeratin-7Bile Duct DiseaseCell Biologymedicine.diseaseImmunohistochemistryBile Ducts IntrahepaticCell Transformation Neoplasticmedicine.anatomical_structureBile Duct NeoplasmsKeratinKeratin 7KeratinsGallbladder NeoplasmsbusinessCytokeratin 20 (CK20)HumanPathology - Research and Practice
researchProduct

Molecular imaging of gastroenteropancreatic neuroendocrine tumors.

2010

Somatostatin-receptor scintigraphy has become an obligatory molecular imaging method in the management of patients with neuroendocrine tumors when metastatic disease is suspected. Using positron emission tomography and new somatostatin analogues, sensitivity of somatostatin receptor imaging has further increased. With a combination of morphologic imaging methods, such as hybrid imaging by PET/CT, this method represents the method of choice in many centers and efforts are under way to translate somatostatin receptor imaging onto a cellular level by endoscopic confocal microscopy. Other clinically relevant functional pathways in neuroendocrine tumors that are accessible by PET imaging are glu…

medicine.medical_specialtyPathologyNeuroendocrine tumorsScintigraphylaw.inventionConfocal microscopylawmedicineHumansReceptors SomatostatinGastrointestinal NeoplasmsMicroscopy Confocalmedicine.diagnostic_testbusiness.industrySomatostatin receptorGastroenterologyPet imagingmedicine.diseaseCarcinoma NeuroendocrineMolecular ImagingPancreatic NeoplasmsNeuroendocrine TumorsSomatostatinPositron emission tomographyPositron-Emission TomographyRadiologyMolecular imagingRadiopharmaceuticalsbusinessGastroenterology clinics of North America
researchProduct

Teratoma with a malignant somatic component in pediatric patients: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience

2010

Background Teratoma with a malignant somatic component (TMSC) is rare but described in adults, whereas information on pediatric presentation is sparse. Procedure The Associazione Italiana Ematologia Oncologia Pediatrica identified 14 cases of TMSC. Clinical files and pathology specimens were reviewed. Results The series (9 female, 5 male) showed the following disease: testis (2), sacrococcygeal (3), ovary (3), retroperitoneum (3), mediastinum (2), and foot soft tissue (1). Distribution of the somatic component was: carcinoma (4), pancreatic neuroendocrine tumor (1), neuroblastoma (3), rhabdomyosarcoma (3), rhabdomyosarcoma plus liposarcoma, chondrosarcoma, neurogenic sarcoma (1), chondrosar…

medicine.medical_specialtyPathologybusiness.industryMalignant peripheral nerve sheath tumorHematologyLiposarcomamedicine.diseaseOncologyPediatrics Perinatology and Child HealthmedicineCarcinomaRadiologyGerm cell tumorsTeratomaSarcomaChondrosarcomaRhabdomyosarcomabusinessPediatric Blood & Cancer
researchProduct

Spinal Intradural Intramedullary Dissemination in the Absence of Intracranial Relapse of a Previously Radically Treated Temporal Lobe Glioblastoma Mu…

2017

Intracranial glioblastoma multiforme (GBM) constitutes the most frequent and unfortunately aggressive primary central nervous system malignancy. Despite the high tendency of these tumors to show local relapse within the brain after primary therapy, dissemination into the spinal axis is an infrequent event. If spinal metastases occur they are leptomeningeal in the vast majority of cases and always in the context of intracranial progressive disease. Spinal intramedullary metastases of intracranial GBM have rarely been described to date. We report the unique case of a young woman with subacute progressive paraparesis due to spinal intramedullary metastases of a temporal lobe GBM despite the re…

medicine.medical_specialtyPathologymedicine.medical_treatmentCentral nervous systemSpinal intradural intramedullary disseminationContext (language use)Case ReportMalignancylcsh:RC254-282Temporal lobelaw.inventionIntramedullary rod03 medical and health sciences0302 clinical medicinelawmedicineChemotherapybusiness.industrymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.anatomical_structureOncology030220 oncology & carcinogenesisTemporal lobe glioblastoma multiformeRadiologybusiness030217 neurology & neurosurgeryProgressive diseaseGlioblastomaCase Reports in Oncology
researchProduct

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

2008

Introduction Despite many efforts to develop new chemotherapies for metastatic upper gastrointestinal (GI) cancer, overall prognosis continues to be fatal, particularly in gastric and pancreatic cancer. Many of these patients deserve second-or third-line treatment after failure of first-line chemotherapy. Therefore, we analysed toxicity and response rate of weekly docetaxel after failed upfront regimes in these upper GI cancer patients. Patients and Methods Between 2001 and 2006, 18 patients received docetaxel based regimes (35 mg/m2 weekly) after informed consent. Response rates were determined using RECIST criteria or tumor progression if clinically evident. Toxicities were graded based o…

medicine.medical_specialtyPathologymedicine.medical_treatmentSalvage therapyNeutropeniachemotherapygastriclcsh:RC254-282GastroenterologysalvageInternal medicinePancreatic cancermedicinedocetaxelOriginal ResearchChemotherapyLeukopeniabusiness.industryCancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemetastaticRegimenOncologyDocetaxelmedicine.symptombusinessmedicine.drugClinical medicine. Oncology
researchProduct

Incidence Patterns and Trends of non-Central Nervous System Solid Tumours in Children and Adolescents. A Collaborative Study of the Spanish Populatio…

2016

Journal Article; OBJECTIVE To describe incidence patterns and trends in children (0-14 years) and adolescents (15-19 age-range) with solid tumours, except those of central nervous system (CNS), in Spain. METHODS Cases were drawn from eleven Spanish population-based cancer registries. Incidence was estimated for the period 1983-2007 and trends were evaluated using Joinpoint regression analysis. RESULTS The studied tumour groups accounted for 36% of total childhood cancers and 47.6% of those diagnosed in adolescence with annual rates per million of 53.5 and 89.3 respectively. In children 0 to 14 years of age, Neuroblastoma (NB) was the commonest (7.8%) followed by Soft-tissue sarcomas (STS) (…

medicine.medical_specialtyPediatricsJoinpoint regression:Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms Germ Cell and Embryonal::Neuroectodermal Tumors::Neoplasms Neuroepithelial::Neuroectodermal Tumors Primitive::Neuroectodermal Tumors Primitive Peripheral::Neuroblastoma [Medical Subject Headings]Central nervous systemEspaña03 medical and health sciences0302 clinical medicine030225 pediatricsInternal medicineNeuroblastoma:Health Care::Population Characteristics::Demography::Vital Statistics::Morbidity::Incidence [Medical Subject Headings]medicineCarcinoma:Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms Glandular and Epithelial::Carcinoma [Medical Subject Headings]canceradolescentsAdolescente:Named Groups::Persons::Age Groups::Child [Medical Subject Headings]childhood:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]business.industryIncidence (epidemiology)Cancermedicine.diseaseNeoplasiasSpanish populationmedicine.anatomical_structureOncologyEl Niñopopulation-based studySpain030220 oncology & carcinogenesisNiño:Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings]solid tumourincidence:Diseases::Neoplasms::Neoplasms by Site::Bone Neoplasms [Medical Subject Headings]businessIncidenciaResearch PaperSpain.
researchProduct

Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms in Germany: a Multi-Institutional Registry Study with Prospective Follow Up on 450…

2013

68 Ga-DOTATOC PET in patients with neuroendocrine tumors (NET). We specifically looked for incremental lesions, defined as lesions only observed on one modality even after extensive retrospective evaluation of the other modality. Methods: Twenty patients with a metastasized NET underwent 111 In-pentetreotide

medicine.medical_specialtyPediatricsgenetic structuresPeptide receptorbusiness.industryRegistry studyHematologyNeuroendocrine tumorsmedicine.diseaseOncologyRadionuclide therapyotorhinolaryngologic diseasesmedicineIn patientRadiologyReceptorbusinesspsychological phenomena and processesAnnals of Oncology
researchProduct